Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs Milestone Pharmaceuticals Inc. (MIST)

Cognition Therapeutics, Inc. and Milestone Pharmaceuticals Inc. are both Biotechnology companies. Cognition Therapeutics, Inc. and Milestone Pharmaceuticals Inc. are of similar size ($88.7M and $85.1M). Cognition Therapeutics, Inc. has the higher net margin (0.00% vs −1,586.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Cognition Therapeutics, Inc. leads on 11 and Milestone Pharmaceuticals Inc. on 2.

Valuation

Metric CGTX MIST Biotechnology median
P/E n/m n/m 8.68
P/S n/m 20.16 10.29
P/B 2.39 5.86 2.40
Price to free cash flow n/m n/m 20.52
EV/EBITDA n/m 0.06 0.68
EV/Sales n/m (0.87) 10.15
Earnings yield (19.54%) (89.61%) (28.86%)
Free cash flow yield (22.44%) (57.72%) (22.44%)

Profitability

Metric CGTX MIST Biotechnology median
Gross margin 0.00% 13.27% 65.16%
Operating margin 0.00% (1,479.69%) 0.00%
Net margin 0.00% (1,586.01%) 0.00%
Free cash flow margin 0.00% (1,163.79%) 0.00%
Return on equity (83.76%) (35,522.62%) (56.66%)
Return on assets (57.33%) (73.36%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CGTX MIST Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 62.79% (11.94%) 30.08%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX MIST Biotechnology median
Debt to equity 0.00 3.25 0.00
Current ratio 7.03 8.13 4.72
Net debt to EBITDA 0.78 0.79 0.96

Dividend

Metric CGTX MIST Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric CGTX MIST Biotechnology median
Market cap 85.12m 88.66m 150.40m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack